EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of Aldosterone Synthase Inhibitor Baxdrostat on Albuminuria in CKD and Uncontrolled Hypertension

Jamie P Dwyer iD, Robin Myte iD, Hiddo J L Heerspink iD, Glenn M Chertow iD, Noha Maklad, Brendon L Neuen iD, Dimitris Kardassis iD, Nataliia Zaozerska, Dustin J Little iD

Clinical Journal of the American Society of Nephrology · 21.10.2026

DOI: 10.2215/cjn.0000001248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 21.10.2026. Verfasst von Jamie P Dwyer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Floyd School of Medicine, University of South Carolina, Columbia, South Carolina. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

BPCKDaldosteroneclinical trialhypertensionsystolic BP

Autor:innen und Institutionen

  • Department of Internal Medicine, Floyd School of Medicine, University of South Carolina, Columbia, South Carolina.
  • Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
  • The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Departments of Medicine, Epidemiology and Population Health, and Health Policy Division of Nephrology, Stanford University School of Medicine, Stanford, California.
  • Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.

ORCID-Profile: Jamie P Dwyer, Robin Myte, Hiddo J L Heerspink, Glenn M Chertow, Brendon L Neuen, Dimitris Kardassis, Dustin J Little

Förderung

  • AstraZeneca

Zitieren

APA

Dwyer, J. P., Myte, R., Heerspink, H. J. L., Chertow, G. M., Maklad, N., Neuen, B. L., Kardassis, D., Zaozerska, N., & Little, D. J. (2026). Effects of Aldosterone Synthase Inhibitor Baxdrostat on Albuminuria in CKD and Uncontrolled Hypertension. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.0000001248

Vancouver

Dwyer JP, Myte R, Heerspink HJL, Chertow GM, Maklad N, Neuen BL, et al. Effects of Aldosterone Synthase Inhibitor Baxdrostat on Albuminuria in CKD and Uncontrolled Hypertension. Clinical Journal of the American Society of Nephrology. 2026. doi:10.2215/cjn.0000001248

BibTeX
@article{Dwyer2026,
  author = {Dwyer, Jamie P and Myte, Robin and Heerspink, Hiddo J L and Chertow, Glenn M and Maklad, Noha and Neuen, Brendon L and Kardassis, Dimitris and Zaozerska, Nataliia and Little, Dustin J},
  title = {Effects of Aldosterone Synthase Inhibitor Baxdrostat on Albuminuria in CKD and Uncontrolled Hypertension},
  journal = {Clinical Journal of the American Society of Nephrology},
  year = {2026},
  doi = {10.2215/cjn.0000001248}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche